APAPP
ACE App

Program Overview & Target Audience

This activity has been designed to meet the educational needs of nurse practitioners (NPs), physician assistants (PAs), PharmDs, and other healthcare professionals who are currently managing and treating patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

​

Learning Objectives

• Analyze the latest diagnostic criteria for PAH and PH-ILD to improve early detection and patient outcomes.

• Evaluate the safety and efficacy of current pharmacological treatments for PAH and PH-ILD, including antifibrotic therapy.

• Apply multidisciplinary approaches to the management of PAH and PH-ILD patients, to enhance patient care.
   

Accreditation Information

In support of improving patient care, this activity has been planned and implemented by the Annenberg Center for Health Sciences at Eisenhower and Focus Medical Communications. Annenberg Center for Health Sciences at Eisenhower is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

​

Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.00 ANCC contact hour, which includes 0.50 pharmacology credits.

 

Annenberg Center for Health Sciences at Eisenhower has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

​

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit. Credit will be provided to the NABP CPE Monitor within 60 days after the activity is completed.

This activity is certified as a knowledge-based CPE.

​

Disclosure of Relevant Financial Relationships

All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience all relevant financial relationships related to the content of the presentation or enduring material. Full disclosure of all relevant financial relationships will be made in writing to the audience prior to the activity. All other staff at the Annenberg Center for Health Sciences at Eisenhower and Focus Medical Communications, who impacted the content of this activity, have no relevant financial relationships to disclose.

​

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to mitigating all relevant financial relationships that could arise as a result of individuals who control activity content and who have relevant financial relationships with ACCME-defined ineligible companies. The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with relevant financial relationships that can be reconciled with the goals and educational integrity of the CE activity.

All relevant financial relationships disclosed during this activity have been mitigated.

Fee information: There is no fee for this educational activity.
 

​

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Focus Medical Communications.

 

 

 

 

​

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and
United Therapeutics Corporation.